EUVIMEDEUVIMED entdecken
KommentarKohortenstudieOpen Access · CC BY 4.0

Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study

B B Bet iD, M A Lugthart iD, I H Linskens, M C van Maarle, E van Leeuwen, E Pajkrt

Ultrasound in Obstetrics & Gynecology · 2024

DOI: 10.1002/uog.27623 ↗

Kurz gefasst

Kommentar in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2024. Verfasst von B B Bet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Nuchal Translucency Measurement, Pregnancy Outcome, Pregnancy Trimester, First, Crown-Rump Length. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

An increased nuchal translucency (NT) thickness of ≥ 3.5 mm is a well‐established marker for congenital anomalies and adverse pregnancy outcome between 11 and 14 weeks' gestation, but little is known about its performance as a screening tool before 11 weeks. We aimed to investigate, in a prospective setting, whether fetuses with increased NT before 11 weeks are at risk for adverse pregnancy outcome.

Methods

This was a prospective cohort study including pregnant women with a viable fetus with NT ≥ 2.5 mm and a crown–rump length (CRL) < 45 mm. All included women were referred to our fetal medicine unit (FMU) and scheduled for a follow‐up scan where the NT was remeasured after 1 week when the CRL was > 45 mm. Two groups were evaluated: cases with a normalized NT (< 3.5 mm) and cases with persistently increased NT (≥ 3.5 mm). The cases were monitored until 4 weeks after delivery. The main outcome was a composite adverse outcome of aneuploidy, other genetic disorders, structural anomalies and pregnancy loss. We performed subgroup analyses of NT thickness at inclusion and normalized or persistently increased NT at follow‐up.

Results

The study included 109 cases, of which 39 (35.8%) had an adverse pregnancy outcome. Of these, 64.1% (25/39) were aneuploid, corresponding to 22.9% (25/109) of the total study population. In the subgroups of NT thickness at inclusion of 2.5–3.4 mm, 3.5–4.4 mm and ≥ 4.5 mm, an adverse outcome was reported in 22.0% (9/41), 40.0% (18/45) and 52.2% (12/23), respectively. In fetuses with a normalized NT and without ultrasound abnormalities at the follow‐up scan, the incidence of adverse outcome was 8.5% (5/59), of which 5.1% (3/59) cases were aneuploid.

Conclusions

Fetuses with an early increased NT thickness are at considerable risk of an adverse pregnancy outcome, even if the NT normalizes after 11 weeks. Not all congenital anomalies can be diagnosed with routine first‐trimester screening, such as non‐invasive prenatal testing and/or a first‐trimester anomaly scan. Therefore, expectant parents should always be referred to a FMU for detailed ultrasonography. Invasive prenatal testing should be offered if an increased NT of ≥ 2.5 mm is observed before 11 weeks' gestation. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuchal Translucency MeasurementPregnancy OutcomePregnancy Trimester, FirstCrown-Rump LengthHumansFemalePregnancyProspective StudiesAdultGestational AgeCongenital AbnormalitiesAneuploidy

Stichwörter der Autor:innen

adverse pregnancy outcomeaneuploidy screeningchromosomal anomalyfirst‐trimester anomaly scangenetic disorderinvasive prenatal testingnon‐invasive prenatal testnuchal translucencystructural anomaly

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Reproduction and Development, Amsterdam, The Netherlands.
  • Department of Obstetrics and Gynecology, Amsterdam UMC location Vrije Universiteit, Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: B B Bet, M A Lugthart

Zitieren

APA

Bet, B. B., Lugthart, M. A., Linskens, I. H., van Maarle, M. C., van Leeuwen, E., & Pajkrt, E. (2024). Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.27623

Vancouver

Bet BB, Lugthart MA, Linskens IH, van Maarle MC, van Leeuwen E, Pajkrt E. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study. Ultrasound in Obstetrics & Gynecology. 2024. doi:10.1002/uog.27623

BibTeX
@article{Bet2024,
  author = {Bet, B B and Lugthart, M A and Linskens, I H and van Maarle, M C and van Leeuwen, E and Pajkrt, E},
  title = {Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study},
  journal = {Ultrasound in Obstetrics & Gynecology},
  year = {2024},
  doi = {10.1002/uog.27623}
}
Kostenlos starten →